在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

FLCN Antibody, Biotin conjugated

  • 中文名稱:
    FLCN兔多克隆抗體, Biotin偶聯
  • 貨號:
    CSB-PA008711HD01HU
  • 規格:
    ¥880
  • 其他:

產品詳情

  • 產品名稱:
    Rabbit anti-Homo sapiens (Human) FLCN Polyclonal antibody
  • Uniprot No.:
  • 基因名:
  • 別名:
    BHD antibody; BHD skin lesion fibrofolliculoma protein antibody; Birt Hogg Dube syndrome protein antibody; Birt-Hogg-Dube syndrome protein antibody; DKFZp547A118 antibody; FLCL antibody; Flcn antibody; FLCN_HUMAN antibody; FLJ45004 antibody; FLJ99377 antibody; Folliculin antibody; MGC17998 antibody; MGC23445 antibody
  • 宿主:
    Rabbit
  • 反應種屬:
    Human
  • 免疫原:
    Recombinant Human Folliculin protein (291-579AA )
  • 免疫原種屬:
    Homo sapiens (Human)
  • 標記方式:
    Biotin
  • 克隆類型:
    Polyclonal
  • 抗體亞型:
    IgG
  • 純化方式:
    Antigen Affinity Purified
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液:
    Preservative: 0.03% Proclin 300
    Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    GTPase-activating protein that plays a key role in the cellular response to amino acid availability through regulation of the mTORC1 signaling cascade controlling the MiT/TFE factors TFEB and TFE3. Activates mTORC1 by acting as a GTPase-activating protein: specifically stimulates GTP hydrolysis by RRAGC/RagC or RRAGD/RagD, promoting the conversion to the GDP-bound state of RRAGC/RagC or RRAGD/RagD, and thereby activating the kinase activity of mTORC1. The GTPase-activating activity is inhibited during starvation and activated in presence of nutrients. Acts as a key component for mTORC1-dependent control of the MiT/TFE factors TFEB and TFE3, while it is not involved in mTORC1-dependent phosphorylation of canonical RPS6KB1/S6K1 and EIF4EBP1/4E-BP1. In low-amino acid conditions, the lysosomal folliculin complex (LFC) is formed on the membrane of lysosomes, which inhibits the GTPase-activating activity of FLCN, inactivates mTORC1 and maximizes nuclear translocation of TFEB and TFE3. Upon amino acid restimulation, RRAGA/RagA (or RRAGB/RagB) nucleotide exchange promotes disassembly of the LFC complex and liberates the GTPase-activating activity of FLCN, leading to activation of mTORC1 and subsequent cytoplasmic retention of TFEB and TFE3. Indirectly acts as a positive regulator of Wnt signaling by promoting mTOR-dependent cytoplasmic retention of MiT/TFE factor TFE3. Required for the exit of hematopoietic stem cell from pluripotency by promoting mTOR-dependent cytoplasmic retention of TFE3, thereby increasing Wnt signaling. Acts as an inhibitor of browning of adipose tissue by regulating mTOR-dependent cytoplasmic retention of TFE3. In response to flow stress, regulates STK11/LKB1 accumulation and mTORC1 activation through primary cilia: may act by recruiting STK11/LKB1 to primary cilia for activation of AMPK resided at basal bodies, causing mTORC1 down-regulation. Together with FNIP1 and/or FNIP2, regulates autophagy: following phosphorylation by ULK1, interacts with GABARAP and promotes autophagy. Required for starvation-induced perinuclear clustering of lysosomes by promoting association of RILP with its effector RAB34.
  • 基因功能參考文獻:
    1. Two FLCN mutations have been identified in Birt-Hogg-Dube syndrome patients: One is an insertion mutation previously reported in three Asian families; while the other is the first mutation (originally found in Asian populations) that has ever been detected in a French family. PMID: 29357828
    2. FLCN gene analysis revealed a heterozygous FLCN{NM_144997.5}:c.1285dupC mutation in all affected members. The clinical features of BHD syndrome are heterogeneous with wide intra-familial and interfamilial variation. It is caused by mutations of the FLCN gene. PMID: 28775225
    3. The molecular insight into the folliculin dynamics in the presence and absence of mutations may provide valuable information regarding the interactions essential for normal functioning of cellular process and the molecular basis of Birt-Hogg-Dube syndrome PMID: 27484154
    4. The present identification of two mutations not only further supports the important role of tumor suppressor FLCN in Birt-Hogg-Dube syndrome and primary spontaneous pneumothorax, but also expands the spectrum of FLCN mutations. PMID: 28785590
    5. In the folliculin gene, a similar genotype spectrum but different mutant loci was determined in Chinese patients with Birt-Hogg-Dube syndrome compared with European and American patients. PMID: 28558743
    6. Germline mutations in the FLCN gene are responsible for the autosomal dominant inherited disorder Birt-Hogg-Dube syndrome. PMID: 28970150
    7. Seventy-six of 156 FLCN mutation carriers (120 probands and 36 sibs, 48.7%) had skin papules; however, cutaneous manifestations were so subtle that only one patient voluntarily consulted dermatologists. Japanese Asian BHD families have three FLCN mutational hotspots. PMID: 27220747
    8. A nonsense mutation of FLCN was found in a spontaneous pneumothorax family. The results expand the mutational spectrum of FLCN in patients with Birt-Hogg-Dube syndrome. PMID: 27486260
    9. the study describes the FLCN mutation spectrum in Danish Birt-Hogg-Dube (BHD) syndrome patients, and contributes to a better understanding of BHD syndrome and management of BHD patients. PMID: 27734835
    10. We report Smith-Magenis syndrome who presents bilateral renal tumors. This is most likely related to haploinsufficiency of FLCN gene, located in the deleted region PMID: 27633572
    11. For patients whose clinical features are atypical, detection of germline mutation in FLCN gene would help confirm diagnosis. The 2 mutations we reported would expand the mutation spectrum of FLCN gene associated with BHD syndrome PMID: 27258496
    12. DNA sequence analyses determined that there was a two base pair deletion in exon 4 of the FLCN gene, confirming the diagnosis of BHD syndrome. PMID: 27780965
    13. We identified a hitherto unreported pathogenic FLCN frameshift deletion c.563delT (p.Phe188Serfs*35) in a family of a 46-year-old woman presented with macrohematuria due to bilateral chromophobe renal carcinomas PMID: 26342594
    14. FLCN irregulation in lung cysts of primary spontaneous pneumothorax is not associated with promoter methylation. PMID: 26398834
    15. mTOR inhibitor, sirolimus, suppresses the tumor's growth, suggesting that mTOR inhibitors might be effective in control of FLCN-deficient RCC. PMID: 26418749
    16. we show that glycogen accumulates in kidneys from mice lacking FLCN and in renal tumors from a BHD patient PMID: 26439621
    17. Case Report: FLCN deletion mutation in members of Indian Birt-Hogg-Dube syndrome family. PMID: 25827758
    18. This report documents the first identification of founder mutations in FLCN, as well as expands mutation spectrum of the gene PMID: 25807935
    19. FLCN-related renal cell carcinomas showed overexpression of GPNMB and underexpression of FLCN, whereas sporadic tumors showed inverted patterns. PMID: 25594584
    20. The FLCN-GABARAP association is modulated by the presence of either folliculin-interacting protein (FNIP)-1 or FNIP2 and further regulated by ULK1. PMID: 25126726
    21. Two predominant genes, ephrin type A receptor 6 (EPHA6) and folliculin (FLCN), with mutations exclusive to African American CRCs, are by genetic and biological criteria highly likely African American CRC driver genes. PMID: 25583493
    22. Findings suggest that folliculin deficient renal cell carcinoma cells are highly sensitive to irradiation due to increased autophagic cell death, unlike other types of renal cell carcinoma. PMID: 24434776
    23. A rare mutation of the folliculin gene was detected in the patient and family members with Birt-Hogg-Dube syndrome with pulmonary cysts or pneumothorax, but no skin or renal lesions. PMID: 24346394
    24. Birt-Hogg-Dube (BHD) syndrome is a recently discovered autosomal-dominant disease caused by a mutation in the folliculin gene. PMID: 24996715
    25. loss of FLCN constitutively activates AMPK, resulting in PGC-1alpha-mediated mitochondrial biogenesis and increased ROS production PMID: 24762438
    26. FLCN germ-line mutation is associated with spontaneous pneumothorax and renal cancer PMID: 23264078
    27. Results suggest that Birt-Hogg-Dube (BHD)syndrome-causing FLCN mutants may retain partial functionality. Thus, several BHD symptoms may be due to abnormal levels of FLCN rather than its complete loss. PMID: 23784378
    28. Tumor suppression function of FLCN may be linked to its impact on the cell cycle. PMID: 23874397
    29. FLCN localizes to motile and non-motile cilia, centrosomes and the mitotic spindle. Alteration of FLCN levels can cause changes to the onset of ciliogenesis. In three-dimensional culture, abnormal expression of FLCN disrupts polarized growth of kidney cells and deregulates canonical Wnt signalling. Findings suggest that BHD is a ciliopathy, with symptoms at least partly due to abnormal ciliogenesis. PMID: 23784378
    30. Birt-Hogg-Dube syndrome in a patient with melanoma and a novel mutation in the FCLN gene. PMID: 23414156
    31. FLCN functions as a tumor suppressor by negatively regulating rRNA synthesis. PMID: 23077212
    32. Germline mutation analysis of the FCLN gene in mother and daughter cases with renal cell neoplasms showed a deletion of 18 bp in exon 5(c.332_349del/p.H111_Q116del), predicting an alteration of the amino acid sequence of "HPSHPQ" replaced by a single amino acid, "L". PMID: 22211584
    33. Findings suggest that aspects of folliculin tumour suppressor function are linked to interaction with p0071 and the regulation of RhoA signalling. PMID: 22965878
    34. These data support a model in which dysregulation of the FLCN-p0071 interaction leads to alterations in cell adhesion, cell polarity, and RhoA signaling. PMID: 23139756
    35. These findings identify novel pathways and targets linked to folliculin tumour suppressor activity. PMID: 23155228
    36. FLCN deficiency and subsequent increased PPARGC1A expression result in increased mitochondrial function and oxidative metabolism as the source of cellular energy, which may drive hyperplastic transformation. PMID: 23150719
    37. Study reports a novel in-frame deletion mutation p.F143del (c.427_429delTTC) in exon 6 of FLCN gene in a Korean proband and her two sisters. PMID: 22446046
    38. confirmed a high yield of FLCN mutations in clinically defined BHD families, we found a substantially increased lifetime risk of renal cancer of 16% for FLCN mutation carriers PMID: 22146830
    39. FLCN mutations throughout the coding sequence, and suggest that multiple protein domains contribute to folliculin stability and tumor suppressor activity. PMID: 21538689
    40. Birt-Hogg-Dube (BHD) protein-deficient cells exhibited defects in cell-intrinsic apoptosis that correlated with reduced expression of the BH3-only protein Bim, which was similarly observed in all human and mouse BHD-related tumors examined. PMID: 21258407
    41. Data show that FLCN mutations were found in 9 of 19 (47%) families. PMID: 20618353
    42. This report confirms that large intragenic FLCN deletions can cause Birt-Hogg-Dube syndrome and documents the first large intragenic FLCN duplication in a Birt-Hogg-Dube syndrome patient PMID: 21412933
    43. Genetic testing for Birt-Hogg-Dube should be considered in the treatment algorithm of patients with bilateral renal masses and known oncocytoma PMID: 21496834
    44. FLCN tumor suppressor gene inactivation induces TFE3 transcriptional activity by increasing its nuclear localization PMID: 21209915
    45. plays role in tumor suppression and inhibition on rapamycin pathway PMID: 21079084
    46. Data show that germline FLCN mutations were not detected in 50 patients with familial non-syndromic colorectal cancer. PMID: 20522427
    47. An Birt-Hogg-Dube syndrome protein germline mutation was found in 23 (63.9%) of the 36 patients. A large genomic deletion was identified in two of the remaining 13 patients. PMID: 20413710
    48. We report cases involving a new mutation in three unrelated families of Birt-Hogg-Dube syndrome. PMID: 20227563
    49. Mutations lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dube syndrome PMID: 12204536
    50. Clinical and genetic studies of four sporadic BHD cases and four families with a total of 23 affected subjects PMID: 12471204

    顯示更多

    收起更多

  • 相關疾病:
    Birt-Hogg-Dube syndrome (BHD); Primary spontaneous pneumothorax (PSP); Renal cell carcinoma (RCC)
  • 亞細胞定位:
    Lysosome membrane. Cytoplasm, cytosol. Cell projection, cilium. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle. Nucleus.
  • 蛋白家族:
    Folliculin family
  • 組織特異性:
    Expressed in most tissues tested, including skin, lung, kidney, heart, testis and stomach.
  • 數據庫鏈接:

    HGNC: 27310

    OMIM: 135150

    KEGG: hsa:201163

    STRING: 9606.ENSP00000285071

    UniGene: Hs.31652



主站蜘蛛池模板: 青青青伊人色综合久久| 好大好硬好爽免费视频| 精品久久久久久久中文字幕| 人人妻人人澡人人爽| 色欲一区二区三区精品a片| 精品久久久久久无码人妻蜜桃| 免费能直接看黄的视频| 免费视频爱爱太爽了网站| 国产麻豆剧果冻传媒白晶晶| 色 亚洲 日韩 国产 综合| 国内大量揄拍人妻在线视频| 国产精成a品人v在线播放| 成人av无码国产在线观看| 国产精品视频永久免费播放| 99久久综合狠狠综合久久| 在线综合亚洲欧美网站| 日韩国产精品人妻无码久久久| 欧美潮喷少妇100| 亚洲爆乳大丰满无码专区| 99精品国产一区二区| av色国产色拍| 久久精品亚洲综合专区 | 在线天堂免费观看.www| 久久久久成人精品无码中文字幕| 18禁肉肉无遮挡无码网站| 国产欧美日韩国产高清| 久久综合a∨色老头免费观看| 中文字幕aⅴ在线视频| 日日噜噜噜夜夜爽爽狠狠| 2020每日更新国产精品视频| 18禁无遮挡羞羞污污污污网站| 精品无码成人片一区二区98| 亚洲国产成人一区二区精品区| 午夜精品电影你懂的| 九九久久精品国产波多野结衣| 欧洲精品码一区二区三区免费看| 精品偷自拍另类在线观看| 天码欧美日本一道免费| 无码办公室丝袜ol中文字幕| 亚洲精品tv久久久久久久久久| 国产情侣激情在线视频|